Efficacy of Targeted Therapy in Genetic Subtypes of Aggressive Lymphoma – Module 3

CME: 1.0

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Program Overview

This activity provides an overview of molecular and clinical subtypes of lymphoma and the mechanisms by which targeted therapies work for molecular subtypes.

Learning Objective

Upon completion of this activity, participants should be better able to:

  • Summarize the efficacy of targeted therapy in genetic subtypes of aggressive lymphoma.

Post a comment to this article